Recent research highlights ongoing trials assessing alternatives to intravenous TXA administration.

Read the full article here

About The Author
Catherine Gilliam

Leave a reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.